Ropharma (RPH.RO), one of the top five pharmaceutical groups in Romania, with integrated operations from pharmaceutical production to distribution, pharmacies and hospital, announced RON1.1 million net profit in the first quarter of 2025, slightly up from the RON1 million in the first quarter of 2024.
Total operating revenue almost doubled year-on-year (96.9%) to RON345.1 million.
The first quarter results come after the company announced having overshot the RON1 billion revenue mark in 2024 (RON1.07 billion), up from the RON610 million in 2023.
(English version by Loredana Fratila-Cristescu)
